Nektar Therapeutics
NKTR
NKTR
134 hedge funds and large institutions have $168M invested in Nektar Therapeutics in 2024 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 36 increasing their positions, 35 reducing their positions, and 23 closing their positions.
Holders
134
Holders Change
+10
Holders Change %
+8.06%
% of All Funds
1.95%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
36
Increased
36
Reduced
35
Closed
23
Calls
$50K
Puts
$77K
Net Calls
-$27K
Net Calls Change
-$468K
Top Buyers
1 |
SC
1
Samlyn Capital
New York
|
$11.7M |
2 |
2
BlackRock
New York
|
$18.8M |
3 |
EAM
3
Eventide Asset Management
Boston,
Massachusetts
|
$9.34M |
4 |
4
Citadel Advisors
Miami,
Florida
|
$8.62M |
5 |
5
State Street
Boston,
Massachusetts
|
$3.71M |